Abstract CT108: Immunogenicity of Poly-ICLC Matured Dendritic Cells As an Adjuvant for NY-ESO-1 and Melan-A-MART-1 Peptide Vaccination Compared to Montanide® ISA-51 VG, in Study Subjects with Melanoma in Complete Clinical Remission but at High Risk of Disease Recurrence
Cancer Research（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined